Leukemia, Erythroblastic, Acute - 25 Studies Found
Recruiting |
: Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia :
: |
Active, not recruiting |
: Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy :
|
Completed |
: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma :
|
Completed |
: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
|
Terminated |
: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Terminated |
: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant :
|
Completed |
: Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia :
|
Active, not recruiting |
: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia :
|
Completed |
: Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia :
|
Terminated |
: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia :
|